newsfilter
← Latest News
PR Newswire·

Karyopharm to Participate in Baird's Biotech Discovery Series

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the...